BPG is committed to discovery and dissemination of knowledge
Review
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Apr 28, 2015; 7(6): 874-884
Published online Apr 28, 2015. doi: 10.4254/wjh.v7.i6.874
Liver cirrhosis in hepatic vena cava syndrome (or membranous obstruction of inferior vena cava)
Santosh Man Shrestha
Santosh Man Shrestha, Liver Foundation Nepal, Sitapaela Height, Kathmandu, Nepal
Author contributions: The author solely contributed to this work.
Conflict-of-interest: The author has no conflict of interest.
Correspondence to: Santosh Man Shrestha, MBBS, DTM&H, MRCP, FRCPE, Liver Foundation Nepal, Sitapaela Height, Ward No 2, Kathmandu, Nepal. smshrestha1938@gmail.com
Telephone: +977-1-4033275
Received: July 4, 2014
Peer-review started: July 11, 2014
First decision: August 28, 2014
Revised: December 30, 2014
Accepted: January 15, 2015
Article in press: January 19, 2015
Published online: April 28, 2015
Processing time: 301 Days and 6.9 Hours
Core Tip

Core tip: Previously considered congenital and diagnosed late hepatic vena cava syndrome (HVCS) is a dynamic life-long disease related to bacterial infection that begins insidiously often in childhood and leads to development of cirrhosis and hepatocellular carcinoma. Localized stenosis, the sequel of the initial lesion persists life-long makes it vulnerable to subsequent bacterial infection which is followed by thrombosis in inferior vena cava (IVC) and intra-hepatic veins resulting in recurrent ischemic liver damage. As it frequently occurs as a co-morbid condition in patients with chronic hepatitis B or C infection or alcohol use, patients with cirrhosis in developing countries should be assessed for presence of HVCS by ultrasonography of IVC.